- Home
- SMTI vs SERA Comparison
SMTI vs SERA Comparison
Compare SMTI & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- SERA
- Stock Information
- Founded
- SMTI 1982
- SERA 2008
- Country
- SMTI United States
- SERA United States
- Employees
- SMTI N/A
- SERA N/A
- Industry
- SMTI Medical/Dental Instruments
- SERA Precision Instruments
- Sector
- SMTI Health Care
- SERA Health Care
- Exchange
- SMTI Nasdaq
- SERA Nasdaq
- Market Cap
- SMTI 288.2M
- SERA 208.7M
- IPO Year
- SMTI N/A
- SERA 2021
- Fundamental
- Price
- SMTI $33.01
- SERA $8.35
- Analyst Decision
- SMTI Buy
- SERA
- Analyst Count
- SMTI 1
- SERA 0
- Target Price
- SMTI $44.00
- SERA N/A
- AVG Volume (30 Days)
- SMTI 36.2K
- SERA 79.3K
- Earning Date
- SMTI 11-12-2024
- SERA 11-06-2024
- Dividend Yield
- SMTI N/A
- SERA N/A
- EPS Growth
- SMTI N/A
- SERA N/A
- EPS
- SMTI N/A
- SERA N/A
- Revenue
- SMTI $78,056,873.00
- SERA $94,000.00
- Revenue This Year
- SMTI $29.95
- SERA N/A
- Revenue Next Year
- SMTI $19.68
- SERA $4,471.43
- P/E Ratio
- SMTI N/A
- SERA N/A
- Revenue Growth
- SMTI 24.66
- SERA N/A
- 52 Week Low
- SMTI $26.00
- SERA $4.90
- 52 Week High
- SMTI $43.25
- SERA $12.36
- Technical
- Relative Strength Index (RSI)
- SMTI 34.95
- SERA 57.84
- Support Level
- SMTI $31.13
- SERA $7.91
- Resistance Level
- SMTI $34.22
- SERA $8.60
- Average True Range (ATR)
- SMTI 1.80
- SERA 0.58
- MACD
- SMTI -0.63
- SERA 0.07
- Stochastic Oscillator
- SMTI 12.98
- SERA 67.96
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.